UNSPSC 41181943: Tumor-associated antigen immunological test system tests

In this classification, a Tumor-associated antigen immunological test system tumor associated antigen immunological test system that consists of the reagents used to identify by immunochemical techniques Tumor-associated antigen immunological test system based tumors. US FDA regulates Tumor-associated antigen immunological test system under 21 CFR &and under FDA product code NVA.

UNSPSC 41181943 Tumor-associated antigen immunological test system tests, a Commodity code, does not align with the work state and local governments are actually procuring under this classifier. The recent opportunities tagged to this code span laboratory testing services (phlebotomy, specimen collection, oil analysis), equipment repair and maintenance (sterilizers, washers, spectrophotometers, chargers), facility design services, and testing equipment procurement — none of which involve tumor-associated antigen immunological testing. The mismatch suggests this code is either misapplied in source systems or sees no genuine demand in state and local procurement at present.

The code shows activity across multiple issuing-body types — Marion County, Oregon (corrections health services); Texas Department of State Health Services; the City of Tampa (waste-to-energy operations); Lubbock Power & Light (utility laboratory services); Harris County Toll Road Authority; the City of Orlando (water reclamation); Broward County Transportation Department; the Town of Waterford, Connecticut; Santa Clara County (public health); the City of Ocala Electric Utility; the City of Palm Bay (water treatment); Lamar University; and Texas A&M University System — but their procurement needs bear no meaningful relationship to the code's stated commodity. Recent solicitations include Marion County's ITB for laboratory testing and phlebotomy services (due July 24, 2026); Texas DSHS's IFB for laboratory equipment repair and maintenance at its South Texas facility (due July 6, 2026); and Lubbock Power & Light's RFP for annual insulating oil analysis and laboratory services for approximately 20 substations (due July 22, 2026). Unless your firm specializes in tumor-associated antigen immunological assay systems and can identify state or local health department demand outside these recent postings, this code warrants a skip.